Evidence that platelets from transfusion-dependent β-thalassemia patients induce T cell activation.
暂无分享,去创建一个
I. Papassotiriou | E. Solomou | A. Kattamis | A. Mantzou | P. Delaporta | P. Diamantopoulos | Christina-Nefeli Kontandreopoulou | Christina Salamaliki | N. Vyniou | Marianna Tzannoudaki | Foteini Perganti | Ioannis Papassotiriou | P. Diamantopoulos | Athina Vyniou
[1] G. Tsokos,et al. The role of platelets in immune-mediated inflammatory diseases , 2023, Nature Reviews Immunology.
[2] A. Kattamis,et al. Thalassaemia , 2022, The Lancet.
[3] T. Barnetche,et al. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis , 2021, Science Translational Medicine.
[4] M. Tremblay,et al. Platelets release mitochondrial antigens in systemic lupus erythematosus , 2021, Science Translational Medicine.
[5] J. Semple,et al. The Immune Nature of Platelets Revisited , 2020, Transfusion Medicine Reviews.
[6] M. Klein,et al. Specialized regulatory T cells control venous blood clot resolution through SPARC. , 2020, Blood.
[7] V. Viprakasit,et al. Changing patterns in the epidemiology of β‐thalassemia , 2020, European journal of haematology.
[8] Robert A. Campbell,et al. FcγRIIA expression aggravates nephritis and increases platelet activation in systemic lupus erythematosus in mice. , 2020, Blood.
[9] J. Hansen,et al. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism. , 2020, Blood.
[10] D. Alexopoulos,et al. Platelets from patients with myocardial infarction can activate T cells , 2020, Haematologica.
[11] Duncan R. Smith,et al. Platelet proteome reveals specific proteins associated with platelet activation and the hypercoagulable state in β-thalassmia/HbE patients , 2019, Scientific Reports.
[12] S. Subramaniam,et al. Innate Effector-Memory T-Cell Activation Regulates Post-Thrombotic Vein Wall Inflammation and Thrombus Resolution. , 2016, Circulation research.
[13] A. Weyrich,et al. Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases. , 2016, Physiological reviews.
[14] M. Schattner,et al. Platelets: New Bricks in the Building of Neutrophil Extracellular Traps , 2016, Front. Immunol..
[15] C. Jenne,et al. Platelets and coagulation in infection , 2016, Clinical & translational immunology.
[16] A. Michelson,et al. Platelet Physiology , 2016, Seminars in Thrombosis and Hemostasis.
[17] P. Nigrovic,et al. Platelets: active players in the pathogenesis of arthritis and SLE , 2012, Nature Reviews Rheumatology.
[18] S. Fucharoen,et al. Platelet activation and platelet–leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis , 2012, Annals of Hematology.
[19] W. Baldwin,et al. Platelets Present Antigen in the Context of MHC Class I , 2012, The Journal of Immunology.
[20] D. Wagner,et al. How platelets safeguard vascular integrity , 2011, Journal of thrombosis and haemostasis : JTH.
[21] N. Young,et al. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients. , 2008, Experimental hematology.
[22] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[23] K. Rezvani,et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. , 2007, Blood.
[24] P. Thiagarajan,et al. P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates , 2000, Circulation.